Indonesia approves emergency use of China's mRNA COVID-19 vaccine

STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog

INDONESIA-SURAKARTA-COVID-19-VACCINATION

INDONESIA-SURAKARTA-COVID-19-VACCINATION

(220322) -- SURAKARTA, March 22, 2022 (Xinhua) -- A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)

INDONESIA-SURAKARTA-COVID-19-VACCINATION

INDONESIA-SURAKARTA-COVID-19-VACCINATION

(220322) -- SURAKARTA, March 22, 2022 (Xinhua) -- A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)

INDONESIA-SURAKARTA-COVID-19-VACCINATION

INDONESIA-SURAKARTA-COVID-19-VACCINATION

(220322) -- SURAKARTA, March 22, 2022 (Xinhua) -- A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)

Animation, job hunting drive popularity of Japanese-language stud

Animation, job hunting drive popularity of Japanese-language stud

TOKYO, Japan - Andi Lukito from Indonesia works full-time at a store of Lawson Inc., a major convenience store chain operator, in Tokyo's Setagaya Ward on Sept. 17. (Kyodo)